Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Summary of Impact of Error on Condensed Consolidated Balance Sheets) (Details)

v3.24.1.u1
Basis of Presentation (Summary of Impact of Error on Condensed Consolidated Balance Sheets) (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Assets            
Prepaid research and development costs $ 924,583   $ 1,006,252 $ 5,871,005    
Total current assets 45,137,301   22,933,222 43,372,058    
Total assets 71,800,359   50,023,091 70,337,351    
Liabilities and Stockholders' Equity            
Accrued research and development costs       8,774,187    
Total current liabilities 9,566,363   17,810,732 34,247,744    
Total liabilities 26,590,715   30,344,930 48,525,614    
Accumulated deficit (275,070,138)   (256,768,209) (236,113,448)    
Total stockholders' equity 45,209,644 $ 51,602,272 19,678,161 21,811,737 $ 49,190,761 $ 82,797,317
Total liabilities and stockholders' equity $ 71,800,359   $ 50,023,091 70,337,351    
As Reported [Member]            
Assets            
Prepaid research and development costs       5,787,224    
Total current assets       43,288,277    
Total assets       70,253,570    
Liabilities and Stockholders' Equity            
Accrued research and development costs       13,786,241    
Total current liabilities       39,259,798    
Total liabilities       53,537,668    
Accumulated deficit       (241,209,283)    
Total stockholders' equity       16,715,902    
Total liabilities and stockholders' equity       70,253,570    
Adjustment [Member]            
Assets            
Prepaid research and development costs       83,781    
Total current assets       83,781    
Total assets       83,781    
Liabilities and Stockholders' Equity            
Accrued research and development costs       (5,012,054)    
Total current liabilities       (5,012,054)    
Total liabilities       (5,012,054)    
Accumulated deficit       5,095,835    
Total stockholders' equity       5,095,835    
Total liabilities and stockholders' equity       $ 83,781